Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities w...
Egile Nagusiak: | Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Elsevier
2018
|
Antzeko izenburuak
-
Modeling Fragile X Syndrome in Drosophila
nork: Małgorzata Drozd, et al.
Argitaratua: (2018-04-01) -
Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
nork: Alessandra Tempio, et al.
Argitaratua: (2023-04-01) -
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
nork: Thomas Maurin, et al.
Argitaratua: (2018-12-01) -
A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
nork: Tovi Anderson, et al.
Argitaratua: (2013-01-01) -
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
nork: Sara Castagnola, et al.
Argitaratua: (2017-11-01)